Coronary circulation
•Download as PPTX, PDF•
1 like•134 views
The document discusses treatment for acute coronary syndrome (ACS) including ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina (USA). It lists potential causes like pulmonary embolism, acute pericarditis, aortic dissection and provides recommendations on tests like electrocardiogram (ECG), troponin levels, CT scans, and echocardiograms. It then discusses reperfusion options like thrombolysis or primary percutaneous coronary intervention (PCI) depending on time since symptoms. It provides guidance on medications for the acute phase and secondary prevention.
Report
Share
Report
Share
Recommended
Sopa de letras en ingles
The document contains medical terms related to the right side of the heart, including the right ventricle, tricuspid valve, right atrium, and septal valve. It also mentions diagnostic tests and procedures like echocardiograms and valvuloplasty that are used to evaluate and treat conditions of the right heart.
STEMI - Cath Lab
Primary PCI is superior to thrombolysis for STEMI treatment, with lower mortality and reinfarction rates. Stents provide better outcomes than balloon angioplasty alone. Door-to-balloon times under 120 minutes are optimal. For facilities without PCI capabilities, rapid transfer for primary PCI within 2 hours is recommended over thrombolysis if possible. Facilitated PCI, using drugs to establish early reperfusion before angioplasty, combines benefits of early reperfusion and easier intervention. Pre-procedural TIMI flow grade is a determinant of PCI success and outcomes.
Percutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarctionhttps://aiimsbhubaneswar.nic.in/
Unstable angina (UA), acute non-ST elevation myocardial infarction (NSTEMI), and acute ST elevation myocardial infarction (STEMI) are the three presentations of acute coronary syndromes (ACS). The first step in the management of patients with ACS is prompt recognition, since the beneficial effects of therapy are greatest when performed soon after hospital presentation. For patients presenting to the emergency department with chest pain suspicious for an ACS, the diagnosis of myocardial infarction can be confirmed by the electrocardiogram (ECG) and serum cardiac biomarker elevation; the history is relied upon heavily to make the diagnosis of unstable anginaDr.yadavemboliz2
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles ranging in size from individual cells to large plaque fragments. Occlusion devices temporarily block blood flow to trap debris. Outcomes data suggests protection devices may reduce complications like stroke, no reflow, and death when used for high-risk procedures such as carotid stenting. Larger randomized controlled trials are still needed to further validate the benefits of embolic protection.
Dr.yadavemboliz2
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination with stenting reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.
Embolic protection devices yadav- cleveland clinic
Embolic protection devices yadav- cleveland clinicSociety for Heart Attack Prevention and Eradication
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination with stenting reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.Embolic protection devices
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination of stenting and embolic protection reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.
Ecg dibbs 290321_fy1
This document provides an overview of interpreting electrocardiograms (ECGs). It discusses:
1) The basic concepts of ECG interpretation including using a systematic approach, identifying acute situations, and avoiding basic errors.
2) How to analyze different aspects of the ECG including rate, rhythm, axis, P wave, PR interval, QRS complex, ST segment, QT interval, and T wave.
3) Examples of different cardiac conditions that present with abnormal ECG patterns such as myocardial infarction, arrhythmias, conduction abnormalities, pericarditis, and Brugada syndrome.
Recommended
Sopa de letras en ingles
The document contains medical terms related to the right side of the heart, including the right ventricle, tricuspid valve, right atrium, and septal valve. It also mentions diagnostic tests and procedures like echocardiograms and valvuloplasty that are used to evaluate and treat conditions of the right heart.
STEMI - Cath Lab
Primary PCI is superior to thrombolysis for STEMI treatment, with lower mortality and reinfarction rates. Stents provide better outcomes than balloon angioplasty alone. Door-to-balloon times under 120 minutes are optimal. For facilities without PCI capabilities, rapid transfer for primary PCI within 2 hours is recommended over thrombolysis if possible. Facilitated PCI, using drugs to establish early reperfusion before angioplasty, combines benefits of early reperfusion and easier intervention. Pre-procedural TIMI flow grade is a determinant of PCI success and outcomes.
Percutaneus coronary intervention in Non ST elevation myocardial infarction
Percutaneus coronary intervention in Non ST elevation myocardial infarctionhttps://aiimsbhubaneswar.nic.in/
Unstable angina (UA), acute non-ST elevation myocardial infarction (NSTEMI), and acute ST elevation myocardial infarction (STEMI) are the three presentations of acute coronary syndromes (ACS). The first step in the management of patients with ACS is prompt recognition, since the beneficial effects of therapy are greatest when performed soon after hospital presentation. For patients presenting to the emergency department with chest pain suspicious for an ACS, the diagnosis of myocardial infarction can be confirmed by the electrocardiogram (ECG) and serum cardiac biomarker elevation; the history is relied upon heavily to make the diagnosis of unstable anginaDr.yadavemboliz2
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles ranging in size from individual cells to large plaque fragments. Occlusion devices temporarily block blood flow to trap debris. Outcomes data suggests protection devices may reduce complications like stroke, no reflow, and death when used for high-risk procedures such as carotid stenting. Larger randomized controlled trials are still needed to further validate the benefits of embolic protection.
Dr.yadavemboliz2
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination with stenting reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.
Embolic protection devices yadav- cleveland clinic
Embolic protection devices yadav- cleveland clinicSociety for Heart Attack Prevention and Eradication
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination with stenting reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.Embolic protection devices
Embolic protection devices aim to prevent stroke and other complications during carotid artery procedures by capturing debris released during stenting or angioplasty. Several filter-based and occlusion-based devices have been developed, with filter designs including supported nitinol frames and unsupported mesh. Clinical trials show filter devices can retrieve numerous embolic particles from procedures without interrupting blood flow. Larger trials are currently underway to determine if combination of stenting and embolic protection reduces stroke risk compared to carotid endarterectomy. Embolic protection may benefit high-risk patients and procedures like SVGs, acute MI, and renal angioplasty.
Ecg dibbs 290321_fy1
This document provides an overview of interpreting electrocardiograms (ECGs). It discusses:
1) The basic concepts of ECG interpretation including using a systematic approach, identifying acute situations, and avoiding basic errors.
2) How to analyze different aspects of the ECG including rate, rhythm, axis, P wave, PR interval, QRS complex, ST segment, QT interval, and T wave.
3) Examples of different cardiac conditions that present with abnormal ECG patterns such as myocardial infarction, arrhythmias, conduction abnormalities, pericarditis, and Brugada syndrome.
Cardiac decison making
This document discusses cardiac decision making and provides guidance on testing options for various patient cases. It outlines tools like CT coronary angiography, cardiac MRI, nuclear scans, PET scans, stress tests, and IVUS/OCT. It provides recommendations on when to use each test based on factors like pre-test probability, symptoms, risk factors, and prior procedures. The document also analyzes several patient cases and suggests the best testing approach for each case.
Cardiology Opinion for Diabetic patients
This document provides guidance from a cardiologist on various questions that diabetologists may have regarding their patients. It recommends obtaining an ECG for all diabetic patients on diagnosis and follow-up. It provides guidance on when to refer to a cardiologist based on symptoms like palor, elevated JVP, hypertension, abnormal pulse, pedal swelling, or cardiac sounds. It discusses evaluating chest pain and breathlessness and the tests that may be needed. It also provides guidance on heart failure management in diabetic patients, use of aspirin and statins, selecting antihypertensives and antidiabetic medications, and when to advise coronary angiography.
Cardiogenic shock
This document discusses circulatory failure and shock, presenting 12 case studies. It defines shock as a profound disturbance of circulation and metabolism leading to inadequate organ perfusion. It describes types of shock including hypovolemic, cardiogenic, obstructive, and distributive shock. Clinical signs of shock are listed. First and second line agents for treating different types of shock are provided, including fluids, vasopressors, inotropes, and other medications. The case studies present patients in shock from various causes and ask how each would be treated.
Clinical Approach to Valvular heart dis
1. This document discusses the clinical approach to valvular heart disease, covering topics like distribution, etiology, symptoms, physical exam findings, investigations and treatment for various valve diseases.
2. Key valve diseases covered are mitral stenosis, mitral regurgitation, aortic stenosis, aortic regurgitation and tricuspid regurgitation. Etiology, symptoms and physical exam findings that help differentiate these conditions are explained.
3. Investigations discussed include chest x-ray, ECG and echocardiogram. Treatment options provided for different severe valve diseases include diuretics, rate control, anticoagulation as well as valve repairs and replacements.
SGLT2i
This document discusses the use of SGLT2 inhibitors (SGLT2i) in managing diabetes. It presents three case studies of patients with diabetes and cardiovascular complications who may benefit from SGLT2i treatment. It summarizes clinical trial data showing that empagliflozin lowers HbA1c, fasting plasma glucose, body weight, and blood pressure compared to other antidiabetic drugs. Empagliflozin also reduces visceral and subcutaneous fat. The document concludes that SGLT2i like empagliflozin provide glycemic control and cardiovascular benefits and can be considered as an addition to metformin for treating diabetes.
ACUTE RHEUMATIC FEVER
Rheumatic heart disease is caused by group A streptococcal infections leading to acute rheumatic fever which can cause long-term damage to heart valves. It most commonly affects the mitral valve. The pathology involves fibrinous necrosis, proliferative nodules, and eventual fibrosis. Recurrences increase the risk of permanent heart damage. Prompt treatment of streptococcal infections and long-term antibiotic prophylaxis can help prevent recurrent rheumatic fever and progressive heart valve damage.
HEART FAILURE MANAGEMENT
This document discusses heart failure, including its causes, clinical presentation, assessment, and management. It provides information on hemodynamics in heart failure, how to clinically recognize and differentiate various types of heart failure based on volume status and perfusion. It outlines how to assess the severity of heart failure using scales like NYHA and ACC/AHA classifications. The document reviews ordering appropriate tests to make a diagnosis and provides guidance on immediate management with oxygen, diuretics, or other therapies, as well as long-term management through pharmacotherapy, devices, diet, and surgery if needed.
HEART FAILURE
This document discusses heart failure, including its causes, clinical presentation, assessment, and management. It provides information on hemodynamics in heart failure, how to clinically recognize and differentiate various types of heart failure based on volume status and perfusion. It outlines approaches for assessing severity, ordering appropriate tests, and managing patients with both acute and long-term heart failure through pharmacological therapies, procedures like CRT and LVAD, and potentially stem cell therapy or transplant. Key signs, symptoms, and treatments are summarized.
Supraventricular tachycardia: ECG recognition and diagnosis
This document discusses diagnosis and management of supraventricular tachycardia (SVT). It provides an overview of different types of SVT such as atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), atrial fibrillation (AF), and atrial flutter (AFL). It describes approaches to differentiate between these types based on electrocardiogram (ECG) patterns such as P wave morphology, PR and RP intervals. The document emphasizes using a physiological approach and considering the beginning and termination of the arrhythmia. It provides tips on localizing accessory pathways and discusses appropriate management strategies for different SVT types
Svt mi 2018
Supraventricular tachycardia is a common complication of myocardial infarction, occurring in 25-44% of cases. It most often develops within 24 hours of an acute myocardial infarction and carries a worse prognosis when associated with anterior wall MIs. Late-onset or persistently irregular supraventricular tachycardia for over 48 hours is associated with poor outcomes. Effective treatment involves managing the underlying hemodynamic instability with beta blockers, amiodarone, or direct current cardioversion while balancing the risks of anticoagulation in the post-MI period.
Resistant hypertension
Resistant hypertension is defined as uncontrolled blood pressure despite treatment with three or more antihypertensive medications, including a diuretic. Pseudo-resistant hypertension accounts for around 50% of cases due to issues like inaccurate measurements, poor medication adherence, and inadequate treatment regimens. Ambulatory blood pressure monitoring is important for accurately diagnosing and managing resistant hypertension. Treatment involves optimizing medication regimens with medications like chlorthalidone, spiranolactone, and amiloride-hydrochlorothiazide combinations, and considering interventions for refractory cases involving more than five medications.
PROSTHETIC HEART VALVES
This document discusses various valve surgeries and prosthetic heart valves. It begins with an overview of common valve interventions like balloon mitral valvuloplasty and transcatheter aortic valve implantation. It then presents two case studies of patients requiring mitral valve surgery. The document compares medical versus surgical management and repair versus replacement. It also reviews considerations for different valve surgeries and types of prosthetic valves, including mechanical and bioprosthetic options. Post-operative care and potential complications are discussed. The document concludes by revisiting the case studies to outline treatment plans.
2015 svt guideline final 19.10.2015
This document provides guidelines for treating various types of supraventricular tachycardia (SVT). It discusses 5 case studies of patients presenting with SVT and the recommended treatment approaches. The document also summarizes the acute and ongoing treatment recommendations for different SVT rhythms including AV nodal reentrant tachycardia, atrioventricular reentrant tachycardia, inappropriate sinus tachycardia, focal atrial tachycardia, atrial flutter, multifocal atrial tachycardia, junctional tachycardia, and SVT in pregnancy or those with congenital heart disease. Treatment options include medications like beta blockers, calcium channel blockers, antiarrhythmics and cardio
surgical approach of cyanotic congenital heart disease
This document discusses the surgical approaches for cyanotic congenital heart disease. It begins with an introduction and overview of topics to be covered, including fetal and adult circulation physiology. It then discusses various defects such as transposition of the great arteries, tetralogy of Fallot, and total anomalous pulmonary venous return. It outlines the history of various palliative and corrective surgeries performed over time, such as Blalock-Taussig shunts, cavopulmonary connections, and arterial switch operations. It provides guidance on timing of surgeries based on disease type and clinical status. It also discusses complications of the Fontan procedure. The document aims to close gaps in understanding regarding why certain surgeries are
interpretation of hemodynamic data
This document discusses various hemodynamic parameters and waveforms seen in different cardiac conditions:
- It compares pressures, waveforms and compliance in conditions like constrictive pericarditis, right ventricular failure, cardiac tamponade and pulmonary hypertension.
- Key waveforms and pressures are described for valvular lesions like mitral stenosis, aortic stenosis, mitral regurgitation and aortic regurgitation.
- Equations for calculating cardiac output, shunt fractions and valvular areas are provided.
- Diagnostic criteria for pseudosevere versus true severe aortic stenosis on stress echocardiography are outlined.
- A case example is presented of a patient evaluated for pulmonary
Dibu's approach to congenital heart disease
This document provides an overview of Dr. Dibbendhu Khanra's approach to congenital heart diseases. It discusses the clinical features that raise suspicion for congenital heart disease, including cyanosis, murmurs, cardiomegaly, and abnormalities on chest x-ray and ECG. It then covers classification of congenital heart diseases into cyanotic vs acyanotic types and outlines approaches to determining the presence, congenital nature, severity and operability of any heart condition based on clinical exam findings. The document agenda includes topics on fetal circulation, heart sounds, murmurs, ECG and chest x-ray patterns in congenital heart disease, and classification systems. Key examination findings that help characterize specific conditions like atrial
Understanding pacemakers
The document provides an overview of pacemaker components, physiology, and programming. It discusses the basic hardware components of pacemakers including the pulse generator, leads, and electrodes. It then covers pacing and sensing principles such as capture, impedance, and sensing thresholds. The remainder summarizes various pacing modes and algorithms for managing arrhythmias, rate response, and minimizing ventricular pacing.
Vit d and cv risks
This document summarizes research on vitamin D deficiency and cardiovascular risks. It discusses how vitamin D metabolism and mechanisms of action may impact cardiovascular outcomes. Several studies are cited showing associations between vitamin D deficiency and increased risks of hypertension, diabetes, heart disease, and mortality. However, the document also notes controversies in the research and calls for more rigorous randomized controlled trials. It outlines objectives and methods for a study examining vitamin D levels in patients with ischemic heart disease. The conclusion is that vitamin D levels correlate with cardiovascular disease and supplementation may help outcomes, but more clinical trials are still needed.
Inf endo dibu
This document discusses guidelines for infective endocarditis and presents 5 case studies. The main points are:
1. Infective endocarditis guidelines have been updated with more diagnostic criteria, organisms, and antibiotic options as well as an expanded role for infectious disease specialists.
2. The case studies demonstrate various presentations of infective endocarditis and treatments including antibiotic regimens and indications for surgery.
3. Key challenges discussed include difficult and culture-negative cases, fungal infective endocarditis, the need for early surgery in some cases, and prophylaxis recommendations.
myocardial Reperfusion injury
1. Despite improvements in reperfusion therapy for STEMI, heart failure rates remain high, partly due to reperfusion injury which accounts for 50% of final infarct size.
2. Ischemic conditioning techniques like ischemic preconditioning and postconditioning have been shown to reduce infarct size in animal models by preparing the heart to be resistant to damage from reperfusion, but have limitations for clinical use.
3. Remote ischemic conditioning using blood pressure cuffs on the arm can provide cardioprotection and may be a promising approach, though more clinical studies are still needed. Pharmacological agents aimed at reducing reperfusion injury have had mixed results and further research is ongoing into strategies like nitrates, adenosine
Nano-gold for Cancer Therapy chemistry investigatory project
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
More Related Content
More from dibufolio
Cardiac decison making
This document discusses cardiac decision making and provides guidance on testing options for various patient cases. It outlines tools like CT coronary angiography, cardiac MRI, nuclear scans, PET scans, stress tests, and IVUS/OCT. It provides recommendations on when to use each test based on factors like pre-test probability, symptoms, risk factors, and prior procedures. The document also analyzes several patient cases and suggests the best testing approach for each case.
Cardiology Opinion for Diabetic patients
This document provides guidance from a cardiologist on various questions that diabetologists may have regarding their patients. It recommends obtaining an ECG for all diabetic patients on diagnosis and follow-up. It provides guidance on when to refer to a cardiologist based on symptoms like palor, elevated JVP, hypertension, abnormal pulse, pedal swelling, or cardiac sounds. It discusses evaluating chest pain and breathlessness and the tests that may be needed. It also provides guidance on heart failure management in diabetic patients, use of aspirin and statins, selecting antihypertensives and antidiabetic medications, and when to advise coronary angiography.
Cardiogenic shock
This document discusses circulatory failure and shock, presenting 12 case studies. It defines shock as a profound disturbance of circulation and metabolism leading to inadequate organ perfusion. It describes types of shock including hypovolemic, cardiogenic, obstructive, and distributive shock. Clinical signs of shock are listed. First and second line agents for treating different types of shock are provided, including fluids, vasopressors, inotropes, and other medications. The case studies present patients in shock from various causes and ask how each would be treated.
Clinical Approach to Valvular heart dis
1. This document discusses the clinical approach to valvular heart disease, covering topics like distribution, etiology, symptoms, physical exam findings, investigations and treatment for various valve diseases.
2. Key valve diseases covered are mitral stenosis, mitral regurgitation, aortic stenosis, aortic regurgitation and tricuspid regurgitation. Etiology, symptoms and physical exam findings that help differentiate these conditions are explained.
3. Investigations discussed include chest x-ray, ECG and echocardiogram. Treatment options provided for different severe valve diseases include diuretics, rate control, anticoagulation as well as valve repairs and replacements.
SGLT2i
This document discusses the use of SGLT2 inhibitors (SGLT2i) in managing diabetes. It presents three case studies of patients with diabetes and cardiovascular complications who may benefit from SGLT2i treatment. It summarizes clinical trial data showing that empagliflozin lowers HbA1c, fasting plasma glucose, body weight, and blood pressure compared to other antidiabetic drugs. Empagliflozin also reduces visceral and subcutaneous fat. The document concludes that SGLT2i like empagliflozin provide glycemic control and cardiovascular benefits and can be considered as an addition to metformin for treating diabetes.
ACUTE RHEUMATIC FEVER
Rheumatic heart disease is caused by group A streptococcal infections leading to acute rheumatic fever which can cause long-term damage to heart valves. It most commonly affects the mitral valve. The pathology involves fibrinous necrosis, proliferative nodules, and eventual fibrosis. Recurrences increase the risk of permanent heart damage. Prompt treatment of streptococcal infections and long-term antibiotic prophylaxis can help prevent recurrent rheumatic fever and progressive heart valve damage.
HEART FAILURE MANAGEMENT
This document discusses heart failure, including its causes, clinical presentation, assessment, and management. It provides information on hemodynamics in heart failure, how to clinically recognize and differentiate various types of heart failure based on volume status and perfusion. It outlines how to assess the severity of heart failure using scales like NYHA and ACC/AHA classifications. The document reviews ordering appropriate tests to make a diagnosis and provides guidance on immediate management with oxygen, diuretics, or other therapies, as well as long-term management through pharmacotherapy, devices, diet, and surgery if needed.
HEART FAILURE
This document discusses heart failure, including its causes, clinical presentation, assessment, and management. It provides information on hemodynamics in heart failure, how to clinically recognize and differentiate various types of heart failure based on volume status and perfusion. It outlines approaches for assessing severity, ordering appropriate tests, and managing patients with both acute and long-term heart failure through pharmacological therapies, procedures like CRT and LVAD, and potentially stem cell therapy or transplant. Key signs, symptoms, and treatments are summarized.
Supraventricular tachycardia: ECG recognition and diagnosis
This document discusses diagnosis and management of supraventricular tachycardia (SVT). It provides an overview of different types of SVT such as atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), atrial fibrillation (AF), and atrial flutter (AFL). It describes approaches to differentiate between these types based on electrocardiogram (ECG) patterns such as P wave morphology, PR and RP intervals. The document emphasizes using a physiological approach and considering the beginning and termination of the arrhythmia. It provides tips on localizing accessory pathways and discusses appropriate management strategies for different SVT types
Svt mi 2018
Supraventricular tachycardia is a common complication of myocardial infarction, occurring in 25-44% of cases. It most often develops within 24 hours of an acute myocardial infarction and carries a worse prognosis when associated with anterior wall MIs. Late-onset or persistently irregular supraventricular tachycardia for over 48 hours is associated with poor outcomes. Effective treatment involves managing the underlying hemodynamic instability with beta blockers, amiodarone, or direct current cardioversion while balancing the risks of anticoagulation in the post-MI period.
Resistant hypertension
Resistant hypertension is defined as uncontrolled blood pressure despite treatment with three or more antihypertensive medications, including a diuretic. Pseudo-resistant hypertension accounts for around 50% of cases due to issues like inaccurate measurements, poor medication adherence, and inadequate treatment regimens. Ambulatory blood pressure monitoring is important for accurately diagnosing and managing resistant hypertension. Treatment involves optimizing medication regimens with medications like chlorthalidone, spiranolactone, and amiloride-hydrochlorothiazide combinations, and considering interventions for refractory cases involving more than five medications.
PROSTHETIC HEART VALVES
This document discusses various valve surgeries and prosthetic heart valves. It begins with an overview of common valve interventions like balloon mitral valvuloplasty and transcatheter aortic valve implantation. It then presents two case studies of patients requiring mitral valve surgery. The document compares medical versus surgical management and repair versus replacement. It also reviews considerations for different valve surgeries and types of prosthetic valves, including mechanical and bioprosthetic options. Post-operative care and potential complications are discussed. The document concludes by revisiting the case studies to outline treatment plans.
2015 svt guideline final 19.10.2015
This document provides guidelines for treating various types of supraventricular tachycardia (SVT). It discusses 5 case studies of patients presenting with SVT and the recommended treatment approaches. The document also summarizes the acute and ongoing treatment recommendations for different SVT rhythms including AV nodal reentrant tachycardia, atrioventricular reentrant tachycardia, inappropriate sinus tachycardia, focal atrial tachycardia, atrial flutter, multifocal atrial tachycardia, junctional tachycardia, and SVT in pregnancy or those with congenital heart disease. Treatment options include medications like beta blockers, calcium channel blockers, antiarrhythmics and cardio
surgical approach of cyanotic congenital heart disease
This document discusses the surgical approaches for cyanotic congenital heart disease. It begins with an introduction and overview of topics to be covered, including fetal and adult circulation physiology. It then discusses various defects such as transposition of the great arteries, tetralogy of Fallot, and total anomalous pulmonary venous return. It outlines the history of various palliative and corrective surgeries performed over time, such as Blalock-Taussig shunts, cavopulmonary connections, and arterial switch operations. It provides guidance on timing of surgeries based on disease type and clinical status. It also discusses complications of the Fontan procedure. The document aims to close gaps in understanding regarding why certain surgeries are
interpretation of hemodynamic data
This document discusses various hemodynamic parameters and waveforms seen in different cardiac conditions:
- It compares pressures, waveforms and compliance in conditions like constrictive pericarditis, right ventricular failure, cardiac tamponade and pulmonary hypertension.
- Key waveforms and pressures are described for valvular lesions like mitral stenosis, aortic stenosis, mitral regurgitation and aortic regurgitation.
- Equations for calculating cardiac output, shunt fractions and valvular areas are provided.
- Diagnostic criteria for pseudosevere versus true severe aortic stenosis on stress echocardiography are outlined.
- A case example is presented of a patient evaluated for pulmonary
Dibu's approach to congenital heart disease
This document provides an overview of Dr. Dibbendhu Khanra's approach to congenital heart diseases. It discusses the clinical features that raise suspicion for congenital heart disease, including cyanosis, murmurs, cardiomegaly, and abnormalities on chest x-ray and ECG. It then covers classification of congenital heart diseases into cyanotic vs acyanotic types and outlines approaches to determining the presence, congenital nature, severity and operability of any heart condition based on clinical exam findings. The document agenda includes topics on fetal circulation, heart sounds, murmurs, ECG and chest x-ray patterns in congenital heart disease, and classification systems. Key examination findings that help characterize specific conditions like atrial
Understanding pacemakers
The document provides an overview of pacemaker components, physiology, and programming. It discusses the basic hardware components of pacemakers including the pulse generator, leads, and electrodes. It then covers pacing and sensing principles such as capture, impedance, and sensing thresholds. The remainder summarizes various pacing modes and algorithms for managing arrhythmias, rate response, and minimizing ventricular pacing.
Vit d and cv risks
This document summarizes research on vitamin D deficiency and cardiovascular risks. It discusses how vitamin D metabolism and mechanisms of action may impact cardiovascular outcomes. Several studies are cited showing associations between vitamin D deficiency and increased risks of hypertension, diabetes, heart disease, and mortality. However, the document also notes controversies in the research and calls for more rigorous randomized controlled trials. It outlines objectives and methods for a study examining vitamin D levels in patients with ischemic heart disease. The conclusion is that vitamin D levels correlate with cardiovascular disease and supplementation may help outcomes, but more clinical trials are still needed.
Inf endo dibu
This document discusses guidelines for infective endocarditis and presents 5 case studies. The main points are:
1. Infective endocarditis guidelines have been updated with more diagnostic criteria, organisms, and antibiotic options as well as an expanded role for infectious disease specialists.
2. The case studies demonstrate various presentations of infective endocarditis and treatments including antibiotic regimens and indications for surgery.
3. Key challenges discussed include difficult and culture-negative cases, fungal infective endocarditis, the need for early surgery in some cases, and prophylaxis recommendations.
myocardial Reperfusion injury
1. Despite improvements in reperfusion therapy for STEMI, heart failure rates remain high, partly due to reperfusion injury which accounts for 50% of final infarct size.
2. Ischemic conditioning techniques like ischemic preconditioning and postconditioning have been shown to reduce infarct size in animal models by preparing the heart to be resistant to damage from reperfusion, but have limitations for clinical use.
3. Remote ischemic conditioning using blood pressure cuffs on the arm can provide cardioprotection and may be a promising approach, though more clinical studies are still needed. Pharmacological agents aimed at reducing reperfusion injury have had mixed results and further research is ongoing into strategies like nitrates, adenosine
More from dibufolio (20)
Supraventricular tachycardia: ECG recognition and diagnosis
Supraventricular tachycardia: ECG recognition and diagnosis
surgical approach of cyanotic congenital heart disease
surgical approach of cyanotic congenital heart disease
Recently uploaded
Nano-gold for Cancer Therapy chemistry investigatory project
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Skin Diseases That Happen During Summer.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
What are the different types of Dental implants.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montrealRecently uploaded (20)
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Coronary circulation
- 2. ACS (STEMI/ NSTEMI/ USA) PULM EMBO ACUTE PERICARDITIS AORTIC DISSECTION ECG TROP I CT – PULM ANGIO/ AORTOGRAM ECHO – LV RWMA/ RA-RV DILATION D-DIMER
- 5. DISTAL LAD
- 6. MID LAD
- 7. PROX LAD
- 34. THROMBOLYSE ( STK/TNK/ RTP)TNK: <6HRS,YOUNG PRIMARY PCI NTG INFUSION FOR PAIN/ MORPHINE <3 HRS:TLT=PPCI 3-6HRS: PCI>TLT 6-12HRS: PCI>>TLT >12 HRS: PCI>>>TLT (IFWMI, ST ELEVATIONOR ANGINA) 12-24 HRS: PPCI BEST 24-48 HRS: PPCI OK 48-72 HRS: PPCI CONSIDERABLE >72 HRS:VIABLITY (IF NO ANGINA) IF NOTVIABLE: NO POINT OF INTERVENTION
- 35. LOADINGASPIRIN 325 STATIN 40-80 CLOPI 300/ PASU 60/TICA 180 (NOTWITHTLT) ASPIRIN 150 STATIN 40-80 CLOPIDOGREL 75 OD,PASUGREL 10 OD,TICAGRELOR 90 BD BETA BLOCKER LIFELONG (no hf) / IVABRADINE ACEI/ARB IF AWMI/ EF<40% NITRATE/ NICORANDIL/ RANOLAZINE/TRIMETAZIDINE ALDACTONE IF EF<40% HEPARIN/ ENOXAPARIN FOR 5-7 DAYS